Physician profile
Vasileios Vasilakis
NPI 1255623153
$1,704.32
in general payments reported to CMS, 2019-2025
11 companies · $698 in 2025
The $698 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $715 · 2020: $30.33 · 2021: $56.75 · 2023: $63.39 · 2024: $141 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691 · Long Term Medical Supply Or Device Loan: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.56 |
| Long Term Medical Supply Or Device Loan | $211.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $590.60 | 2019 | |
| Abbvie INC. | $264.08 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Integra Lifesciences Corporation | $211.31 | 2025 | Durasorb Monofilament Mesh |
| Allergan, INC. | $181.52 | 2019-2021 | |
| Davol INC. | $154.38 | 2025 | |
| Baxter Healthcare | $107.33 | 2025 | |
| Hologic Sales and Service, LLC | $71.71 | 2025 | Coolseal Generator |
| Pacira Pharmaceuticals Incorporated | $31.67 | 2025 | Exparel |
| Lifenet Health | $30.95 | 2025 | Theragenesis Wound Matrix |
| Motiva USA, LLC | $30.44 | 2025 | |
| Merz North America, INC. | $30.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vasileios Vasilakis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.